Third Eye Diagnostics, Inc.

Conduct prototype development and clinical studies leading to the commercialization of Cerepress™, a non-invasive intracranial pressure (ICP) monitor. The monitor gathers pressure measurements externally from the eye of patients with a head injury or who have suffered a stroke. Existing standard-of-care devices that monitor ICP are invasive and require drilling a hole through the patient’s skull to measure pressure, which can expose patients to significant complications, and poses a significant and preventable cost to the U.S. healthcare system.